Sanjay Rajagopalan Selected Research

Sanjay Rajagopalan Research Topics

Disease

38	Inflammation (Inflammations) 01/2022 - 09/2003
32	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 09/2003
32	Atherosclerosis 01/2022 - 05/2002
22	Insulin Resistance 11/2020 - 09/2007
18	Heart Failure 05/2021 - 03/2003
17	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
12	Hypertension (High Blood Pressure) 03/2022 - 08/2003
11	Peripheral Arterial Disease 01/2020 - 09/2002
10	Obesity 03/2022 - 09/2007
9	Chronic Renal Insufficiency 01/2020 - 11/2003
8	Atherosclerotic Plaque (Atheroma) 01/2022 - 11/2009
8	Weight Loss (Weight Reduction) 01/2022 - 09/2007
8	Myocardial Infarction 01/2021 - 09/2003
6	Fibrosis (Cirrhosis) 01/2022 - 09/2003
6	Diabetes Mellitus 01/2020 - 11/2011
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 08/2003
5	Stroke (Strokes) 11/2021 - 09/2009
5	Neoplasms (Cancer) 01/2020 - 07/2007
5	Ischemia 12/2012 - 02/2002
4	Atrial Fibrillation 12/2021 - 07/2009
4	Intermittent Claudication 10/2011 - 10/2003
3	Hyperglycemia 01/2022 - 10/2014
3	Overweight 01/2019 - 04/2004
3	Body Weight (Weight, Body) 01/2016 - 01/2010
2	Vascular Diseases (Vascular Disease) 01/2022 - 04/2008
2	Arteritis 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 01/2020 - 11/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 10/2017
2	Dyslipidemias (Dyslipidemia) 01/2018 - 04/2008
2	Acute Coronary Syndrome 06/2017 - 07/2004
2	Hypertrophy 06/2015 - 09/2003
2	Weight Gain 04/2015 - 08/2012
2	Ventricular Remodeling 12/2013 - 07/2012
2	Metabolic Diseases (Metabolic Disease) 08/2013 - 01/2013
2	Infarction (Infarctions) 12/2012 - 07/2004

Drug/Important Bio-Agent (IBA)

37	Particulate MatterIBA 01/2021 - 06/2004
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2011
10	LipidsIBA 01/2022 - 01/2006
10	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2005
9	Insulin (Novolin)FDA Link 12/2019 - 01/2010
9	IncretinsIBA 01/2018 - 01/2013
7	CalciumIBA 07/2022 - 08/2005
7	Biological ProductsIBA 01/2021 - 07/2007
7	Air Pollutants (Pollutants, Air)IBA 01/2019 - 02/2009
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2005
6	GadoliniumIBA 01/2019 - 11/2009
6	Pharmaceutical PreparationsIBA 01/2019 - 08/2011
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 01/2003
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2004
5	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2017 - 05/2002
4	CholesterolIBA 03/2022 - 10/2014
4	Lipoproteins (Lipoprotein)IBA 01/2022 - 07/2007
4	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2005
4	Messenger RNA (mRNA)IBA 01/2022 - 12/2009
4	C-Reactive ProteinIBA 12/2021 - 07/2007
4	AntioxidantsIBA 01/2018 - 10/2002
4	OzoneIBA 01/2016 - 08/2013
4	Peptides (Polypeptides)IBA 01/2015 - 03/2011
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2022
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 03/2016
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2003
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 02/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 11/2002
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 03/2019 - 11/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 01/2014
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 01/2010
3	LeptinIBA 01/2016 - 09/2007
3	Thioctic Acid (Lipoic Acid)IBA 01/2015 - 01/2010
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 03/2003
3	Angiotensin IIIBA 03/2011 - 07/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2008 - 05/2003
3	Mineralocorticoid Receptor AntagonistsIBA 03/2006 - 05/2002
3	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2005 - 02/2002
3	AldosteroneIBA 07/2004 - 03/2003
2	Uric Acid (Urate)IBA 01/2022 - 01/2022
2	ApolipoproteinsIBA 12/2021 - 12/2009
2	CreatinineIBA 05/2021 - 03/2003
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 11/2020 - 11/2015
2	TroponinIBA 01/2020 - 12/2019
2	oxidized low density lipoproteinIBA 03/2019 - 01/2006
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2016
2	AerosolsIBA 01/2018 - 10/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 11/2003
2	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018 - 10/2014
2	EnzymesIBA 01/2018 - 06/2010
2	Spironolactone (Aldactone)FDA LinkGeneric 09/2017 - 03/2006
2	CCR2 ReceptorsIBA 01/2017 - 01/2014
2	SootIBA 01/2016 - 04/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2015 - 09/2009
2	CytokinesIBA 11/2015 - 06/2015
2	Therapeutic UsesIBA 01/2015 - 01/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 10/2014 - 01/2006
2	Angiotensin Receptor AntagonistsIBA 05/2013 - 03/2006
2	Hormones (Hormone)IBA 02/2013 - 04/2008

Therapy/Procedure

21	Therapeutics 12/2021 - 11/2002
5	Renal Dialysis (Hemodialysis) 12/2013 - 10/2006
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
3	Precision Medicine 01/2019 - 04/2012
2	Secondary Prevention 06/2017 - 04/2008